FDA Clears AviClear® as a Long-Term Treatment for Mild to Severe Acne

Stock Information for Cutera Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cutera Inc.

Cutera Announces Voluntarily Delisting from Nasdaq
Cutera Takes Steps to Strengthen Financial Foundation and Position the Company for Long-Term Success
Notice to Long-Term Shareholders of Cutera, Inc. (CUTR): Grabar Law Office Is Investigating Claims on Your Behalf
Cutera® Announces Partnership with the Adaptive Training Foundation
Cutera® Announces Third Quarter 2024 Financial Results
Attention Long-Term Shareholders of Cutera, Inc. (CUTR): Grabar Law Office Is Investigating Claims on Your Behalf
Cutera® to Announce Third Quarter Results on November 7, 2024
Notice to Current Long-Term Shareholders of Cutera, Inc. (CUTR): Grabar Law Office Is Investigating Claims on Your Behalf

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.